These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 11607816)
1. Modeling Philadelphia chromosome positive leukemias. Wong S; Witte ON Oncogene; 2001 Sep; 20(40):5644-59. PubMed ID: 11607816 [TBL] [Abstract][Full Text] [Related]
2. Model mice for BCR/ABL-positive leukemias. Honda H; Hirai H Blood Cells Mol Dis; 2001; 27(1):265-78. PubMed ID: 11358387 [TBL] [Abstract][Full Text] [Related]
3. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model. Kometani K; Aoki M; Kawamata S; Shinozuka Y; Era T; Taniwaki M; Hattori M; Minato N Cancer Res; 2006 Oct; 66(20):9967-76. PubMed ID: 17047059 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional activation of human LIM-HOX gene hLH-2 in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl. Wu HK; Minden MD Biochem Biophys Res Commun; 1997 May; 234(3):742-7. PubMed ID: 9175786 [TBL] [Abstract][Full Text] [Related]
5. [Detection of bcr/abl gene expression on bone marrow cell colonies in chronic myelogenous leukemia by reverse transcriptase-polymerase chain reaction]. Luo Z; Chen H; Luo S; Tang L; Wang J Hunan Yi Ke Da Xue Xue Bao; 1999; 24(5):418-20. PubMed ID: 12080671 [TBL] [Abstract][Full Text] [Related]
6. Autocrine and paracrine effects of an ES-cell derived, BCR/ABL-transformed hematopoietic cell line that induces leukemia in mice. Peters DG; Klucher KM; Perlingeiro RC; Dessain SK; Koh EY; Daley GQ Oncogene; 2001 May; 20(21):2636-46. PubMed ID: 11420675 [TBL] [Abstract][Full Text] [Related]
7. [The effect of anti-bcr-abl hammerhead ribozyme on bone marrow purging]. Wu Y; Chen YZ; Huang HF; Chen P; Lu LH Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Sep; 35(9):859-63. PubMed ID: 12958661 [TBL] [Abstract][Full Text] [Related]
8. Retroviral transduction models of Ph+ leukemia: advantages and limitations for modeling human hematological malignancies in mice. Van Etten RA Blood Cells Mol Dis; 2001; 27(1):201-5. PubMed ID: 11358380 [TBL] [Abstract][Full Text] [Related]
9. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells]. Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781 [TBL] [Abstract][Full Text] [Related]
10. Cytogenetic characterization of a BCR-ABL transduced mouse cell line. Rudolph C; Hegazy AN; von Neuhoff N; Steinemann D; Schröck E; Stripecke R; Klein C; Schlegelberger B Cancer Genet Cytogenet; 2005 Aug; 161(1):51-6. PubMed ID: 16080957 [TBL] [Abstract][Full Text] [Related]
11. Purging of chronic myelogenous leukemia cells by retrovirally expressed anti-bcr-abl ribozymes with specific cellular compartmentalization. Mendoza-Maldonado R; Zentilin L; Fanin R; Giacca M Cancer Gene Ther; 2002 Jan; 9(1):71-86. PubMed ID: 11916246 [TBL] [Abstract][Full Text] [Related]
12. Role of p21(WAF1/CIP1) as an attenuator of both proliferative and drug-induced apoptotic signals in BCR-ABL-transformed hematopoietic cells. Forster K; Obermeier A; Mitina O; Simon N; Warmuth M; Krause G; Hallek M Ann Hematol; 2008 Mar; 87(3):183-93. PubMed ID: 17960378 [TBL] [Abstract][Full Text] [Related]
13. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation. Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172 [TBL] [Abstract][Full Text] [Related]
14. Biological effects of T315I-mutated BCR-ABL in an embryonic stem cell-derived hematopoiesis model. Melkus M; Bennaceur-Griscelli A; Valogne Y; Flamant S; Chomel JC; Sorel N; Bonnet ML; Deininger MW; Mitjavila-Garcia MT; Turhan AG Exp Hematol; 2013 Apr; 41(4):335-45.e3. PubMed ID: 23287417 [TBL] [Abstract][Full Text] [Related]
15. Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells. Coppo P; Dusanter-Fourt I; Millot G; Nogueira MM; Dugray A; Bonnet ML; Mitjavila-Garcia MT; Le Pesteur D; Guilhot F; Vainchenker W; Sainteny F; Turhan AG Oncogene; 2003 Jun; 22(26):4102-10. PubMed ID: 12821944 [TBL] [Abstract][Full Text] [Related]
16. Osteopontin is upregulated by BCR-ABL. Flamant S; Kortulewski T; Dugray A; Bonnet ML; Guillier M; Guilhot F; Bourhis JH; Vainchenker W; Tronik-Le Roux D; Turhan AG Biochem Biophys Res Commun; 2005 Aug; 333(4):1378-84. PubMed ID: 15993098 [TBL] [Abstract][Full Text] [Related]
17. Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ABL transgenic mice. Mizuno T; Yamasaki N; Miyazaki K; Tazaki T; Koller R; Oda H; Honda ZI; Ochi M; Wolff L; Honda H Oncogene; 2008 May; 27(24):3465-74. PubMed ID: 18193087 [TBL] [Abstract][Full Text] [Related]
18. An intron promotes the anti-bcr-abl activities of a retrovirally expressed ribozyme in chronic myeloid leukemia cells. Liu JH; Wu SC; Chen WS; Yen CC; Yang MH; Tsai YC; Chen PM Biochem Biophys Res Commun; 2004 Jun; 318(3):764-72. PubMed ID: 15144904 [TBL] [Abstract][Full Text] [Related]